AHG · Akso Health Group
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Aug 24, 2020; bars on opposite sides are not compared.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AHG
this stock
Akso Health Group
|
$734.02M | -47.8% | -6.4% | — | 0.0% |
|
MCK
Mckesson Corp
|
$103.82B | +8.9% | +3.1% | 23.9 | 2.1% |
|
COR
Cencora, Inc.
|
$61.58B | -4.7% | +9.3% | 24.0 | 2.4% |
|
CAH
Cardinal Health Inc
|
$54.55B | +14.1% | +14.2% | — | 2.7% |
|
HSIC
Henry Schein Inc
|
$10.06B | +18.4% | +5.9% | 26.3 | 6.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Aug 24, 2020; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AHG | -7.9% | -45.4% | -36.5% | -45.4% | -47.8% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -8.3% | -48.4% | -50.0% | -48.4% | -60.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.